92 related articles for article (PubMed ID: 21063244)
1. Screening of deceased organ donors: no easy answers.
Huang RC; Fishman JA
Transplantation; 2011 Jan; 91(2):146-9. PubMed ID: 21063244
[TBL] [Abstract][Full Text] [Related]
2. New technologies for infectious screening of organ donors.
Fishman JA
Transplant Proc; 2011; 43(6):2443-5. PubMed ID: 21839288
[TBL] [Abstract][Full Text] [Related]
3. Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.
Toro C; Benito R; Aguilera A; Bassani S; Rodríguez C; Calderón E; Caballero E; Alvarez P; García J; Rodríguez-Iglesias M; Guelar A; del Romero J; Soriano V;
J Med Virol; 2005 Jun; 76(2):268-70. PubMed ID: 15834870
[TBL] [Abstract][Full Text] [Related]
4. Infection in organ transplantation: risk factors and evolving patterns of infection.
Fishman JA; Issa NC
Infect Dis Clin North Am; 2010 Jun; 24(2):273-83. PubMed ID: 20466270
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant evaluation for infections in donors and recipients of solid organs.
Schaffner A
Clin Infect Dis; 2001 Jul; 33 Suppl 1():S9-14. PubMed ID: 11389516
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new third-generation ARCHITECT rHTLV-I/II assay for blood screening and diagnosis.
Kapprell HP; Stieler M; Oer M; Goller A; Hausmann M; Schochetman G; Devare SG; Qiu X
Diagn Microbiol Infect Dis; 2010 May; 67(1):61-9. PubMed ID: 20227221
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population.
Tseliou PM; Spiliotakara A; Politis C; Spanakis N; Legakis NJ; Tsakris A
Transfus Med; 2004 Jun; 14(3):253-4. PubMed ID: 15180821
[No Abstract] [Full Text] [Related]
8. The risk for Chagas' disease in the Midwestern United States organ donor population is low.
Bryan CF; Tegtmeier GE; Rafik N; Markham LE; Murillo D; Nelson PW; Shield CF; Warady BA; Aeder MI
Clin Transplant; 2004; 18 Suppl 12():12-5. PubMed ID: 15217401
[TBL] [Abstract][Full Text] [Related]
9. Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity.
Kaul DR; Taranto S; Alexander C; Covington S; Marvin M; Nowicki M; Orlowski J; Pancoska C; Pruett TL; Ison MG;
Am J Transplant; 2010 Feb; 10(2):207-13. PubMed ID: 19839982
[TBL] [Abstract][Full Text] [Related]
10. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
11. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
[TBL] [Abstract][Full Text] [Related]
12. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
[TBL] [Abstract][Full Text] [Related]
13. Blood donor testing for HIV-I/II and HTLV-I/II.
Ness PM; Nass CC
Arch Pathol Lab Med; 1994 Apr; 118(4):337-41. PubMed ID: 7909428
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 Dec; 39(50):915, 921-4. PubMed ID: 1979140
[TBL] [Abstract][Full Text] [Related]
15. [Microbiology of transplants].
Pérez JL; Ayats J; Fortún J; de Oña M; Pumarola T
Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):683-90. PubMed ID: 21726920
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank.
Arjmand B; Aghayan SH; Goodarzi P; Farzanehkhah M; Mortazavi SM; Niknam MH; Jafarian A; Arjmand F; Jebelly far S
Cell Tissue Bank; 2009 Aug; 10(3):247-52. PubMed ID: 19037751
[TBL] [Abstract][Full Text] [Related]
17. Risk of prion disease transmission from ocular donor tissue transplantation.
Hogan RN; Brown P; Heck E; Cavanagh HD
Cornea; 1999 Jan; 18(1):2-11. PubMed ID: 9894930
[TBL] [Abstract][Full Text] [Related]
18. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.
Len O; Garzoni C; Lumbreras C; Molina I; Meije Y; Pahissa A; Grossi P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():10-8. PubMed ID: 24476053
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
Lazda VA
Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
